Tysabri - Therapeutic Monoclonal Antibody (MAb) for the Treatment of Multiple Sclerosis, No Country

Print

Although there is no cure for MS, disease-modifying drugs can help reduce the frequency and severity of exacerbations.
 
«Back

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development